Pharmaceutical Discovery and Development
This major prepares students for careers as pharmaceutical scientists in areas of therapeutics discovery, development and commercialization. Pharmaceutical and biotechnology industries are complex and constantly evolving and require diversity of expertise. The goal of this program is to expose students to multiple facets of therapeutics discovery and development. The major curriculum has been designed to cover major aspects involved in discovery, development and commercialization of the therapeutics while simultaneously providing the students with multiple options to pursue related areas of interest.
New and established pharmaceutical companies spend years to translate new scientific discoveries into commercially available products. This translation process requires process development, pre-clinical development, clinical trials and manufacturing under FDA/EMA quality regulations. Successful commercialization also requires significant input throughout development from business development, sales, distribution and marketing in addition to preparations for product launch. These business processes require managers with strong organizational skills and the ability to span the business and technical domains to coordinate resources and deliver timely results.
Topics in the Curriculum
Bioethics Bioinformatics Biomarkers Biostatistics Clinical Pharmacology Clinical Trial Design Drug discovery and testing Economics of drug development Good laboratory practice (GLP), Good clinical practice (GCP), and Good manufacturing practice (GMP) Government regulations and development process High Throughput Screening Personalized medicine Pharmaceutics and Biopharmaceutics Pharmacogenetics, Kinetics, and Dynamics Pharmacogenomics Pre-clinical data analysis Project management cross functional teams during the development process Target validation
In addition to the MBS core (27 units), paid internship and Team Master's Project (12 units), students in the major must select 18 units from the following menu.
Required courses (12 units)
|ALS 401||3.0||Biotechnology-Based Therapeutics||-|
|ALS 407||1.5||Pharmacogenetics and personalized medicine||ALS 300, 330|
|ALS 418||1.5||Biopharmaceutical Quality Assurance and Control||ALS 333|
|ALS 419||1.5||Chemistry, Manufacturing, and Controls Regulation of Pharmaceuticals||-|
|ALS 430||3.0||Advanced Pharmaceutical Discovery||ALS 330|
|ALS 452||1.5||Healthcare Economics||-|
Electives (6 units)
|ALS 433||1.5||Design of clinical trials||ALS 434|
|ALS 434||3.0||Clinical Biostatistics||Math ramp-up|
|ALS 458||3.0||Applied Entrepreneurship||-|
|ALS 470||1.5||Intellectual Property Strategy||-|
|ALS 493||3.0||Independent Research||-|
|ALS 408||3.0||Advanced In Vitro Diagnostics||ALS 320|
High Throughput Technologies & Lab
Students may substitute up to 3.0 units of courses from other approved ALS 400-series courses and CGU courses. Please contact the registrar for the list of approved courses.